Science & Enterprise subscription

Follow us on Twitter

  • See our infographic on Saturday ... https://t.co/915iuVjrta https://t.co/foiMp01PXB
    about 3 hours ago
  • Results from a clinical trial show a drug approved for a rare lymph node disease can stabilize or improve the condi… https://t.co/E66q37t6Ey
    about 10 hours ago
  • New post on Science and Enterprise: Trial Shows Rare Disease Drug Treats Covid-19 Patients https://t.co/nq3C3i5IwP #Science #Business
    about 10 hours ago
  • NY Times ... Covid-19 Changed How the World Does Science, Together https://t.co/a2GEMqNlgg
    about 19 hours ago
  • A smartphone app is collecting individual reports about Covid-19 symptoms and other health conditions to provide ea… https://t.co/gxdMGhThvO
    about 1 day ago

Please share Science & Enterprise

Biotechs Explore Cell Therapy for Covid-19 Antibodies

Coronavirus face mask

Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies

Sanofi, Biotech Partner on RNA Covid-19 Vaccine

SARS-Cov-2 virus

Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections . . . → Read More: Sanofi, Biotech Partner on RNA Covid-19 Vaccine

Engineered Blood Cells Created for Cancer Therapies

Macrophage

An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies

FDA Okays Faster Covid-19 Test, Nixes Home Tests

Coronavirus graphic

The Food and Drug Administration granted an emergency clearance for a point-of-care test to detect for the virus causing novel coronavirus or Covid-19 infections. . . . → Read More: FDA Okays Faster Covid-19 Test, Nixes Home Tests

Case Study Maps Covid-19 Immune Response

Coronavirus

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response

Commentary – Biotech, Trump’s Latest Casino

SARS-Cov-2 virus

If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again. . . . → Read More: Commentary – Biotech, Trump’s Latest Casino

FDA Clears High-Volume Covid-19 Test

Coronavirus

The Food and Drug Administration cleared for use in the U.S. a high-volume diagnostic for the novel coronavirus that can run on automated systems already in place. . . . → Read More: FDA Clears High-Volume Covid-19 Test

Engineered Probiotic Maker Gains $2.3M Seed Funding

Zack Abbott and John Oliver

A developer of genetically-modified bacteria designed to work in the gut is raising $2.3 million more in seed funds to expand its product line. . . . → Read More: Engineered Probiotic Maker Gains $2.3M Seed Funding

Gates Funding Covid-19 Vaccine Delivery Device

Covid-19 illustration

A biotechnology company developing a vaccine for the Covid-19 virus received funding to scale up a delivery device for the vaccine when it’s available. . . . → Read More: Gates Funding Covid-19 Vaccine Delivery Device

Engineered Viruses Deployed to Treat Gut Infections

C. difficile in petri dish

Academic and industry researchers created gene-editing viruses that in lab cultures and mice killed bacteria causing often deadly intestinal infections. . . . → Read More: Engineered Viruses Deployed to Treat Gut Infections